If you have wondered whether estrogen therapy affects long-term brain health, a new Stanford Medicine study may have caught your attention.
Published in Neurology on August 12, 2026, the study found that women who reported using estrogen-only menopausal hormone therapy had lower odds of Alzheimer’s-related brain pathology at autopsy. They also had better memory performance and were more likely to remain independent in daily life.
That finding is meaningful. It is also easy to misunderstand.
Use this study as a tool for asking better questions: not as a reason to start estrogen without personalized medical guidance.
See the Big Finding
Researchers analyzed information from two large cohorts involving more than 21,000 women. They examined clinical data, blood and cerebrospinal fluid biomarkers, and brain autopsies.
The autopsy portion included:
- 258 women who reported estrogen-only menopausal hormone therapy use
- 2,701 women who reported no menopausal hormone therapy use
The researchers looked for two well-known Alzheimer’s-related features:
- Amyloid plaques
- Neurofibrillary tau tangles
They also assessed amyloid plaque density.
Compared with women who did not report menopausal hormone therapy use, estrogen-only therapy users had:
- 35% lower odds of increased Alzheimer’s-related pathology at autopsy
- 39% lower odds of receiving a clinical dementia diagnosis
- Lower odds of memory and functional decline
- Better performance on memory tests
- Better ability to function independently
The study also found lower amyloid burden in blood and cerebrospinal fluid samples from estrogen-only therapy users in one of the living-participant cohorts.
Read the Stanford Medicine study report, or review the published study abstract on PubMed.
Understand What “Estrogen-Only” Means
Start by identifying the type of therapy discussed.
Estrogen-only therapy is generally prescribed for women who do not have a uterus, often after a hysterectomy. When a uterus is present, a progestogen is typically added to help protect the uterine lining from abnormal thickening and cancer.
This Stanford study focused on estrogen-only therapy. It did not provide conclusive evidence about:
- Estrogen-plus-progestin therapy
- Every estrogen formulation
- Every route of administration
- Topical estrogen products
- Women who begin therapy during perimenopause or soon after menopause
- Women who use hormone therapy for the specific purpose of preventing dementia
That distinction matters. Hormone therapy is not one single product or one single experience. Dose, formulation, route, age, health history, and duration can all affect the risk–benefit discussion.
Ask your clinician to name the exact therapy being considered and explain how the study does: or does not: apply to you.
Explore the Timing Window Carefully
Researchers and menopause experts have discussed a possible “window of opportunity” for hormone therapy and brain health.
The idea is straightforward: estrogen may have different effects depending on when therapy begins. Starting closer to menopause onset may be associated with a more favorable overall risk–benefit profile than starting many years later, after vascular and neurodegenerative changes may already be developing.
For many women, the commonly discussed clinical window is:
- Before age 60
- Within approximately 10 years of menopause onset
- When there is a clear reason to use therapy, such as bothersome hot flashes, night sweats, or bone-health concerns
- When the individual has no major contraindications
However, keep the evidence in perspective. The Stanford study did not directly compare women who started estrogen therapy at different ages or at different points in the menopause transition. Many participants were older, and the study authors noted that late initiation may have underestimated a possible benefit associated with earlier use.
That means the timing concept remains important, but it is not a proven dementia-prevention formula.
Guidelines from major menopause organizations generally do not recommend menopausal hormone therapy solely to prevent dementia. They do recognize that starting therapy later in life may carry a less favorable risk–benefit profile, including higher risks related to cardiovascular disease, blood clots, stroke, and dementia.
Treat timing as one part of a larger decision: not as a guarantee of brain protection.
Know What the Study Cannot Prove
This was an observational cohort study. Researchers identified associations between estrogen-only therapy use and several brain and cognitive outcomes. They did not randomly assign women to receive estrogen or a placebo.
Because of that design, the study cannot prove that estrogen therapy caused the lower rates of Alzheimer’s-related pathology or better memory outcomes.
Women who use hormone therapy may differ from non-users in other important ways. They may have differences in:
- Access to health care
- Education
- Cardiovascular health
- Blood pressure
- Physical activity
- Sleep
- Nutrition
- Smoking history
- Other medical conditions
- Genetic risk factors
- The age when therapy began
- The reason therapy was prescribed
Researchers adjusted for several factors, including education, race, and some known health risks. Still, statistical adjustment cannot eliminate every possible source of bias.
The most accurate takeaway is this:
Estrogen-only menopausal hormone therapy was associated with lower odds of Alzheimer’s-related pathology and better cognitive and functional outcomes in this study. The findings do not prove that estrogen prevents dementia.
That distinction protects you from two common errors: assuming hormone therapy is dangerous for every woman, or assuming hormone therapy is a guaranteed brain-health treatment.
Consider Your Complete Health Picture
Use the Stanford findings as part of a broader conversation about your health journey.
A qualified clinician may review:
- Your age and menopause stage
- Your last menstrual period, if known
- Whether menopause occurred naturally, surgically, or earlier than expected
- Whether you have had a hysterectomy
- Your personal and family history of breast, uterine, or ovarian cancer
- Your history of blood clots, stroke, heart disease, or liver disease
- Your blood pressure and cholesterol
- Your migraine history
- Your bone-health goals
- Your current symptoms
- Your preferred formulation and route
- Your personal priorities and comfort level
If you experienced premature ovarian insufficiency, early menopause, or surgical menopause, the conversation may be different. In those situations, clinicians often consider hormone therapy earlier because untreated estrogen loss may affect bone, cardiovascular, and overall health. The appropriate plan still depends on your history and medical needs.
Bring your full story to the appointment. Your symptoms, concerns, risks, and goals all belong in the decision.
Strengthen Your Brain-Health Foundation
Whether or not hormone therapy is right for you, support your brain with practical daily habits.
Prioritize consistent sleep, because fragmented or insufficient sleep can worsen concentration, memory, mood, and decision-making. If sleep disruption is affecting your quality of life, explore Powerful Wellness’s Sweet Dreams sleep improvement course.
Move your body regularly. Walking, strength training, balance work, and other enjoyable activities can support cardiovascular health, mobility, mood, and healthy aging.
Manage blood pressure, blood sugar, and cholesterol with appropriate medical care. Protecting blood-vessel health also supports the brain.
Build nourishing meals around adequate protein, fiber-rich foods, fruits, vegetables, and healthy fats. Avoid chasing one “brain supplement” as a replacement for consistent foundational habits.
Stay socially connected and mentally engaged. Learning, conversation, creativity, and meaningful activities can all help you remain active and involved in your life.
Address brain fog with curiosity rather than fear. Sleep loss, stress, anxiety, medication effects, thyroid conditions, nutrient deficiencies, depression, and hormonal changes can all affect memory and focus. Persistent or worsening symptoms deserve a professional evaluation.
For support during the menopause transition, explore the free Perimenopause Essentials guide.
Ask These Questions at Your Next Visit
Prepare before your appointment so you can make the most of your time.
Ask:
- Would hormone therapy address one of my current health concerns?
- Am I considering estrogen-only therapy or a combined formulation?
- Does my hysterectomy history change my options?
- How would my age and time since menopause affect the decision?
- What benefits are realistic for my symptoms or bone health?
- What risks are most relevant to my personal history?
- Which formulation and route would you recommend, and why?
- How would we monitor my response and reassess the plan?
- Are there non-hormonal options that may help my sleep, hot flashes, mood, or brain fog?
- What symptoms should prompt a follow-up or urgent evaluation?
You do not need to decide immediately. Request clear information. Write down the answers. Bring a trusted support person if that helps. An informed decision is an active step toward feeling vibrant, capable, and in control.
The Bottom Line
The new Stanford study adds valuable evidence to the conversation about estrogen-only menopausal hormone therapy and brain health. It found an association with lower odds of Alzheimer’s-related pathology, better memory, and stronger daily functioning.
It also leaves important questions unanswered.
The findings do not mean that every woman should take estrogen. They do not apply automatically to estrogen-plus-progestin therapy or every product and delivery method. They do not prove that hormone therapy prevents dementia.
Instead, let the study encourage a more informed conversation about timing, formulation, symptoms, medical history, and personal goals. Let it replace fear with thoughtful questions and replace one-size-fits-all advice with individualized care.
Join the Midlife Reset waitlist at midliferesets.com.
Medical Disclaimer
This article is for educational and informational purposes only. It does not provide medical advice, diagnosis, or treatment recommendations. Menopausal hormone therapy may not be appropriate for everyone and should not be started, stopped, or changed without guidance from a qualified health care professional. Discuss your symptoms, risks, treatment options, and brain-health concerns with your clinician. Seek prompt medical attention for sudden confusion, weakness, speech changes, severe headache, or other urgent symptoms.